Unique Pharmaceuticals, Ltd., has announced a voluntary nationwide recall of all sterile drug preparations associated with the outsourcing facility and that have not reached the expiration date listed on the products. Unique is initiating the recall due to FDA’s concerns associated with Unique’s compounding facilities and compounding processes. The FDA contends they present a lack …
Contamination Found at Ameridose
The Food and Drug Administration has found various potential sources of contamination at a drug-making facility that was founded by the same company as the pharmacy that has been linked to the meningitis outbreak, reports WLFI.com. Ameridose, a Massachusetts-based company that manufactures injectable drugs, has been undergoing a month-long inspection of its facilities. Inspectors say …
FDA Rejects Mandatory Special Training To Prescribe Painkillers
The U.S. Food and Drug Administration (FDA) has reported that doctors will not need special training before they can prescribe long-term narcotic painkillers to their patients that can lead to addiction, a ruling that goes against an expert panel’s recommendation, reports The New York Times. However, the FDA did state companies that make drugs such …
Humira Known to Cause Life-Threatening Fungal Infection
Humira is a prescription medicine made to treat arthritis. However, the manufacturing company, Abbott, failed to disclose the risk that it may cause a life-threatening fungal infection. The company is believed to have known this as far back as 2008, even before warning physicians about its use. Since Humira was released in 2003, many people …
$212 Million Botox Verdict Thrown Out After Lawyer Uses Hand Gesture
A $212 million verdict against a Botox company has been ruled unfair after Richmond U.S. District Judge Robert Payne used video captured by a courtroom security camera to watch the plaintiff’s lawyer during his closing arguments, reports valawyersweekly.com. Payne has ordered a new trial after vacating the 2011 jury verdict. Payne, during analysis of the …
Diabetes Drug Actos Doubles Risk Of Cancer With Use Over Two Years
Researchers have found that taking the diabetes drug Actos (generically known as pioglitazone), produced by Takeda Pharmaceuticals, for more than a 2-year time span doubles one’s risk of developing bladder cancer, though the absolute risk remains low, reports Reuters. Canadian researchers conducted the study by looking at records of greater than 115,000 British patients who …